Expression of the adaptor protein Tks5 in human cancer: Prognostic potential

Stylli,Stanley  S.; Luwor,Rodney  B.; Kaye,Andrew  H.; I,Stacey  T.T.; Hovens,Christopher  M.; Lock,Peter

doi:10.3892/or.2014.3310

September-2014 Volume 32 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September-2014 Volume 32 Issue 3

Full Size Image

Article

Expression of the adaptor protein Tks5 in human cancer: Prognostic potential

Authors:
- Stanley S. Stylli
- Rodney B. Luwor
- Andrew H. Kaye
- Stacey T.T. I
- Christopher M. Hovens
- Peter Lock
View Affiliations / Copyright

Affiliations: Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, Victoria 3052, Australia, Department of Biochemistry, La Trobe Institute of Molecular Sciences, La Trobe University, Bundoora, Victoria 3086, Australia, Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, Victoria 3050, Australia
Pages: 989-1002
|
Published online on: July 4, 2014

https://doi.org/10.3892/or.2014.3310
Expand metrics +

Abstract

Tks5 (tyrosine kinase substrate with 5 SH3 domains) is an adaptor protein which cooperates with Src tyrosine kinase to promote the formation of protease-enriched, actin-based projections known as invadopodia, which are utilized by invasive cancer cells to degrade the extracellular matrix (ECM). We previously identified a Src-Tks5-Nck pathway which promotes invadopodium formation and ECM proteolysis in melanoma and breast cancer cells. We therefore sought to investigate the significance of Tks5 expression in human cancers. This was undertaken retrospectively through an immunohistochemical evaluation in tissue microarray cores and through data mining of the public database, Oncomine. Here we showed that Tks5 was expressed at higher levels in the microarray cores of breast, colon, lung and prostate cancer tissues compared to the levels in normal tissues. Importantly, mining of Oncomine datasets revealed a strong correlation between Tks5 mRNA overexpression in a number of cancers with increased metastatic events and a poorer prognosis. Collectively, these findings suggest a clinical association of Tks5 expression in human cancers. It identifies the importance for further investigations in examining the full potential of Tks5 as a relevant prognostic marker in a select number of cancers which may have implications for future targeted therapies.

View Figures

View References

1	Sporn MB: The war on cancer. Lancet. 347:1377–1381. 1996. View Article : Google Scholar : PubMed/NCBI
2	Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
3	Abram CL, Seals DF, Pass I, et al: The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem. 278:16844–16851. 2003. View Article : Google Scholar : PubMed/NCBI
4	Bowden ET, Barth M, Thomas D, Glazer RI and Mueller SC: An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 18:4440–4449. 1999.PubMed/NCBI
5	Buccione R, Caldieri G and Ayala I: Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 28:137–149. 2009. View Article : Google Scholar : PubMed/NCBI
6	Clark ES and Weaver AM: A new role for cortactin in invadopodia: regulation of protease secretion. Eur J Cell Biol. 87:581–590. 2008. View Article : Google Scholar : PubMed/NCBI
7	Clark ES, Whigham AS, Yarbrough WG and Weaver AM: Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 67:4227–4235. 2007. View Article : Google Scholar : PubMed/NCBI
8	Gimona M, Buccione R, Courtneidge SA and Linder S: Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol. 20:235–241. 2008. View Article : Google Scholar
9	Linder S: The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 17:107–117. 2007. View Article : Google Scholar : PubMed/NCBI
10	Linder S and Aepfelbacher M: Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol. 13:376–385. 2003. View Article : Google Scholar : PubMed/NCBI
11	Weaver AM: Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis. 23:97–105. 2006. View Article : Google Scholar : PubMed/NCBI
12	Weaver AM: Cortactin in tumor invasiveness. Cancer Lett. 265:157–166. 2008. View Article : Google Scholar : PubMed/NCBI
13	Webb BA, Jia L, Eves R and Mak AS: Dissecting the functional domain requirements of cortactin in invadopodia formation. Eur J Cell Biol. 86:189–206. 2007. View Article : Google Scholar : PubMed/NCBI
14	Yamaguchi H, Pixley F and Condeelis J: Invadopodia and podosomes in tumor invasion. Eur J Cell Biol. 85:213–218. 2006. View Article : Google Scholar : PubMed/NCBI
15	Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM and Mueller SC: Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 66:3034–3043. 2006. View Article : Google Scholar : PubMed/NCBI
16	Daly RJ: Cortactin signalling and dynamic actin networks. Biochem J. 382:13–25. 2004. View Article : Google Scholar : PubMed/NCBI
17	Li Y, Tondravi M, Liu J, et al: Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res. 61:6906–6911. 2001.PubMed/NCBI
18	Yamaguchi H, Lorenz M, Kempiak S, et al: Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 168:441–452. 2005. View Article : Google Scholar : PubMed/NCBI
19	Staub E, Groene J, Heinze M, et al: An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. J Mol Med. 87:633–644. 2009. View Article : Google Scholar : PubMed/NCBI
20	Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
21	Pao W, Miller V, Zakowski M, et al: EGF receptor gene mutations are common in lung cancers from ‘never smokers’ and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 101:13306–13311. 2004.
22	Zeineldin R, Muller CY, Stack MS and Hudson LG: Targeting the EGF receptor for ovarian cancer therapy. J Oncol. 2010:4146762010. View Article : Google Scholar : PubMed/NCBI
23	Lock P, Abram CL, Gibson T and Courtneidge SA: A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate. The EMBO J. 17:4346–4357. 1998. View Article : Google Scholar : PubMed/NCBI
24	Stylli SS, Stacey TT, Verhagen AM, et al: Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation. J Cell Sci. 122:2727–2740. 2009. View Article : Google Scholar : PubMed/NCBI
25	Fekete A, Bőgel G, Pesti S, Péterfi Z, Geiszt M and Buday L: EGF regulates tyrosine phosphorylation and membrane-translocation of the scaffold protein Tks5. J Mol Signal. 8:82013. View Article : Google Scholar : PubMed/NCBI
26	Balzer EM, Whipple RA, Thompson K, et al: c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene. 29:6402–6408. 2010. View Article : Google Scholar : PubMed/NCBI
27	Oikawa T, Itoh T and Takenawa T: Sequential signals toward podosome formation in NIH-src cells. J Cell Biol. 182:157–169. 2008. View Article : Google Scholar : PubMed/NCBI
28	Seals DF, Azucena EF Jr, Pass I, et al: The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell. 7:155–165. 2005. View Article : Google Scholar : PubMed/NCBI
29	Murphy DA, Diaz B, Bromann PA, et al: A Src-Tks5 pathway is required for neural crest cell migration during embryonic development. PLoS One. 6:e224992011. View Article : Google Scholar : PubMed/NCBI
30	Stylli SS, I ST, Kaye AH and Lock P: Prognostic significance of Tks5 expression in gliomas. J Clin Neurosci. 19:436–442. 2012. View Article : Google Scholar : PubMed/NCBI
31	Zhu HJ, Iaria J and Sizeland AM: Smad7 differentially regulates transforming growth factor β-mediated signaling pathways. J Biol Chem. 274:32258–32264. 1999.
32	Rhodes DR, Yu J, Shanker K, et al: ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
33	Ayala I, Baldassarre M, Caldieri G and Buccione R: Invadopodia: a guided tour. Eur J Cell Biol. 85:159–164. 2006. View Article : Google Scholar : PubMed/NCBI
34	Baldassarre M, Pompeo A, Beznoussenko G, et al: Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell. 14:1074–1084. 2003. View Article : Google Scholar : PubMed/NCBI
35	Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25:9–34. 2006. View Article : Google Scholar
36	Deryugina EI, Ratnikov B, Monosov E, et al: MT1-MMP initiates activation of pro-MMP-2 and integrin αvβ3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res. 263:209–223. 2001.
37	Finak G, Bertos N, Pepin F, et al: Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 14:518–527. 2008. View Article : Google Scholar : PubMed/NCBI
38	Curtis C, Shah SP, Chin SF, et al: The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 486:346–352. 2012.PubMed/NCBI
39	Ma XJ, Dahiya S, Richardson E, Erlander M and Sgroi DC: Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 11:R72009. View Article : Google Scholar : PubMed/NCBI
40	Buchholz M, Braun M, Heidenblut A, et al: Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene. 24:6626–6636. 2005. View Article : Google Scholar : PubMed/NCBI
41	Badea L, Herlea V, Dima SO, Dumitrascu T and Popescu I: Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology. 55:2016–2027. 2008.
42	Iacobuzio-Donahue CA, Maitra A, Olsen M, et al: Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 162:1151–1162. 2003. View Article : Google Scholar : PubMed/NCBI
43	Chen X, Leung SY, Yuen ST, et al: Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 14:3208–3215. 2003. View Article : Google Scholar : PubMed/NCBI
44	Cho JY, Lim JY, Cheong JH, et al: Gene expression signaturebased prognostic risk score in gastric cancer. Clin Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
45	D’Errico M, de Rinaldis E, Blasi MF, et al: Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer. 45:461–469. 2009.PubMed/NCBI
46	Korkola JE, Houldsworth J, Chadalavada RS, et al: Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66:820–827. 2006. View Article : Google Scholar : PubMed/NCBI
47	Barretina J, Taylor BS, Banerji S, et al: Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet. 42:715–721. 2010. View Article : Google Scholar : PubMed/NCBI
48	Skotheim RI, Lind GE, Monni O, et al: Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res. 65:5588–5598. 2005. View Article : Google Scholar : PubMed/NCBI
49	Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG and Kovacs G: High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer. 9:1522009. View Article : Google Scholar : PubMed/NCBI
50	Nindl I, Dang C, Forschner T, et al: Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer. 5:302006. View Article : Google Scholar : PubMed/NCBI
51	Talantov D, Mazumder A, Yu JX, et al: Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res. 11:7234–7242. 2005. View Article : Google Scholar : PubMed/NCBI
52	Bredel M, Bredel C, Juric D, et al: Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 65:8679–8689. 2005. View Article : Google Scholar : PubMed/NCBI
53	Hou J, Aerts J, den Hamer B, et al: Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 5:e103122010. View Article : Google Scholar : PubMed/NCBI
54	Kaiser S, Park YK, Franklin JL, et al: Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 8:R1312007. View Article : Google Scholar : PubMed/NCBI
55	Aoyagi K, Tatsuta T, Nishigaki M, et al: A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells. Biochem Biophys Res Commun. 300:915–920. 2003. View Article : Google Scholar : PubMed/NCBI
56	Anglesio MS, Arnold JM, George J, et al: Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. Mol Cancer Res. 6:1678–1690. 2008. View Article : Google Scholar : PubMed/NCBI
57	Tothill RW, Tinker AV, George J, et al: Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 14:5198–5208. 2008. View Article : Google Scholar : PubMed/NCBI
58	Radvanyi L, Singh-Sandhu D, Gallichan S, et al: The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc Natl Acad Sci USA. 102:11005–11010. 2005. View Article : Google Scholar : PubMed/NCBI
59	Grasso CS, Wu YM, Robinson DR, et al: The mutational landscape of lethal castration-resistant prostate cancer. Nature. 487:239–243. 2012. View Article : Google Scholar : PubMed/NCBI
60	Desmedt C, Piette F, Loi S, et al: Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res. 13:3207–3214. 2007. View Article : Google Scholar
61	Minn AJ, Gupta GP, Siegel PM, et al: Genes that mediate breast cancer metastasis to lung. Nature. 436:518–524. 2005. View Article : Google Scholar : PubMed/NCBI
62	Laurent C, Valet F, Planque N, et al: High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res. 71:666–674. 2011. View Article : Google Scholar : PubMed/NCBI
63	Loi S, Haibe-Kains B, Desmedt C, et al: Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics. 9:2392008. View Article : Google Scholar : PubMed/NCBI
64	Loi S, Haibe-Kains B, Desmedt C, et al: Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol. 25:1239–1246. 2007. View Article : Google Scholar : PubMed/NCBI
65	Lambrechts A, Van Troys M and Ampe C: The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol. 36:1890–1909. 2004. View Article : Google Scholar : PubMed/NCBI
66	Rohatgi R, Nollau P, Ho HY, Kirschner MW and Mayer BJ: Nck and phosphatidylinositol 4,5-bisphosphate synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway. J Biol Chem. 276:26448–26452. 2001. View Article : Google Scholar : PubMed/NCBI
67	Rivera GM, Briceño CA, Takeshima F, Snapper SB and Mayer BJ: Inducible clustering of membrane-targeted SH3 domains of the adaptor protein Nck triggers localized actin polymerization. Curr Biol. 14:11–22. 2004. View Article : Google Scholar : PubMed/NCBI
68	Rowe RG and Weiss SJ: Navigating ECM barriers at the invasive front: the cancer cell-stroma interface. Annu Rev Cell Dev Biol. 25:567–595. 2009. View Article : Google Scholar : PubMed/NCBI
69	Bowden ET, Onikoyi E, Slack R, et al: Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res. 312:1240–1253. 2006. View Article : Google Scholar : PubMed/NCBI
70	Kinley AW, Weed SA, Weaver AM, et al: Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion. Curr Biol. 13:384–393. 2003. View Article : Google Scholar : PubMed/NCBI
71	Oser M, Yamaguchi H, Mader CC, et al: Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J Cell Biol. 186:571–587. 2009. View Article : Google Scholar : PubMed/NCBI
72	Webb BA, Zhou S, Eves R, Shen L, Jia L and Mak AS: Phosphorylation of cortactin by p21-activated kinase. Arch Biochem Biophys. 456:183–193. 2006. View Article : Google Scholar : PubMed/NCBI
73	Gibcus JH, Mastik MF, Menkema L, et al: Cortactin expression predicts poor survival in laryngeal carcinoma. Br J Cancer. 98:950–955. 2008. View Article : Google Scholar : PubMed/NCBI
74	Hofman P, Butori C, Havet K, et al: Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. Br J Cancer. 98:956–964. 2008. View Article : Google Scholar : PubMed/NCBI
75	Sheen-Chen SM, Huang CY, Liu YY, Huang CC and Tang RP: Cortactin in breast cancer: analysis with tissue microarray. Anticancer Res. 31:293–297. 2011.PubMed/NCBI
76	Bonome T, Levine DA, Shih J, et al: A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res. 68:5478–5486. 2008. View Article : Google Scholar : PubMed/NCBI
77	Freije WA, Castro-Vargas FE, Fang Z, et al: Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 64:6503–6510. 2004. View Article : Google Scholar : PubMed/NCBI
78	Giordano TJ, Kuick R, Else T, et al: Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res. 15:668–676. 2009. View Article : Google Scholar : PubMed/NCBI
79	Smith JJ, Deane NG, Wu F, et al: Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 138:958–968. 2010. View Article : Google Scholar : PubMed/NCBI
80	Nakayama R, Mitani S, Nakagawa T, et al: Gene expression profiling of synovial sarcoma: distinct signature of poorly differentiated type. Am J Surg Pathol. 34:1599–1607. 2010.PubMed/NCBI
81	Phillips HS, Kharbanda S, Chen R, et al: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 9:157–173. 2006. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Expression of the adaptor protein Tks5 in human cancer: Prognostic potential

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles